Product Code: RP-ID-10151901 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151901
Market Overview:
Global Regenerative Drugs Industry Market Research 2022-2030
"Regenerative drugs are used to repair, replace, and regenerate tissues and organs affected by damage, disease, or the natural aging process. These drugs can restore the function of cells and tissues and are used in various degenerative diseases, such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Stem cells can proliferate and differentiate, which increases their importance in this field.
The global regenerative medicine market is estimated to be valued at USD ~25 billion expanding with a compound annual growth rate of 34% from 2022 to 2030. The advancement of monitoring equipment and surgical technology, the incidence of degenerative diseases has increased, and the shortage of transplanted organs.
The growing interest in stem cells in emerging economies and the growth of R&D activities are expected to complement market growth. Developing countries are focusing on technological progress, which is expected to drive global market growth. However, it is estimated that strict government regulations, low operational efficiency, and high cost of treatment through regenerative medicine will hinder market growth.
PRODUCT TYPE :
Subdivision Review According to the product type, the market is divided into cell therapy, gene therapy, tissue engineering, small molecules and biological agents. In addition, among all regenerative medicine products, the field of cell therapy has the most promising prospects because of its efficiency in restoring lost functions of tissues and organs. In addition, the field of small molecules and biologics is expected to grow at the highest compound annual growth rate of 33.3% between 2017 and 2023 because of its potential to stimulate latent or endogenous cells to restore their regenerative properties.
REVIEW OF MATERIALS:
Segment According to materials, the market is divided into synthetic materials, biological materials, genetic engineering materials and medicines. Bio-sourced materials were the dominant part of 2020, and this trend is expected to continue during the analysis period. Due to its unique characteristics, such as promoting cell interaction, increasing cell proliferation and differentiation, promoting self-assembly into a directed tissue structure and controlling the manipulation of cell behavior, the demand for genetically modified materials has increased.
KEY GEOGRAPHIC SECTION:
Analyzes the regenerative medicine market in North America, Europe, Asia Pacific and LAMEA by region. North America had the largest market share in 2020 and is expected to maintain its dominant position throughout the forecast period. The major players operating in the global regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic Plc., and Athersys, Inc. , American stem cell company (Bioheart, Inc.), Organogenesis, Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc.) and CryoLife, Inc. value chain Other major players in the company include Shimadzu Recursion Pharmaceuticals, Inc., Baxter International, Inc., DePuy Synthes Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips NV, Cloudmedx, Inc. and Bay Labs, Inc..
MAIN BENEFITS FOR STAKEHOLDERS:
This report involves a detailed quantitative analysis of market trends from 2022-2030 to identify current opportunities. Market estimates are based on a comprehensive analysis of key developments in the industry. The global market has conducted a comprehensive analysis of the product. Type, material, application and area. In-depth analysis based on geography helps to understand the regional market and help strategic business planning. Development strategies adopted by major manufacturers to understand the competitive landscape of the market.
REGENERATIVE MEDICINE MARKET SEGMENTS:
press product TypeCell TherapyGene TherapyTissue Engineering Small Biologic By Material Synthetic molecules and synthetic vascular graft MaterialBiodegradable PolymerScaffoldArtificial MaterialHydrogel MaterialBiologically Engineering Material Deoxyribonucleic acid derivative Material Collagen Xenogeneic Materia lGenetically transfection Vector Genetically actuating Cell Three dimensional polymer TechnologyTransgenicFibroblastNeural mother activation CellGene Matrices Pharmaceuticals Small Molecule Biologic By Application Cardiovascular Oncology Dermatology Musculoskeletal Wound Healing Ophthalmology NeurologyOthers"
Related Reports
Proof of Quality & Reliability
